CONVOY Study

CONVOY is Neuralink's trial of controlling an assistive robotic arm by thought. It is one of Neuralink's 3 implant trials in the United States, alongside PRIME for computer control and VOICE for speech.

What is the CONVOY Study?

CONVOY is registered on ClinicalTrials.gov, the United States government's trial registry, as NCT06710626, and Neuralink launched it in November 2024. It uses the same N1 implant as PRIME, so PRIME participants can join with the implant they already have.

Why the CONVOY Study Exists

A cursor gives a person with paralysis control of a computer. A robotic arm that can reach, grip, and lift a fork gives control of objects in the room, which matters for eating, drinking, and other daily tasks that otherwise need a caregiver.

How it Works

The implant reads the same hand-movement signals from the motor cortex that drive a cursor, and software maps them onto the joints and gripper of the arm. Alex Conley, a PRIME participant with a spinal cord injury, was the first to control a robotic arm with the implant. Nick Wray, who has amyotrophic lateral sclerosis (ALS, a disease that destroys the nerves that control muscle), had not moved his limbs in four years and now feeds himself with the arm.

The Economics of the CONVOY Study

The arm, the implant, and the software are investigational devices, and Neuralink covers the device, the surgery, and study travel for each participant and a caregiver.

Current Status of the CONVOY Study

Neura Pod lists 4 CONVOY participants: Alex Conley, RJ Tanner, Jake Schneider, and Nick Wray. Alex and Jake take part at Barrow Neurological Institute in Phoenix, and RJ and Nick at University of Miami Health, the two hospitals that run both PRIME and CONVOY. In September 2026 another participant, who posts on X as "LeBrain James," took his robotic arm to an Ohio State game.

What Comes Next

The next milestones are formal results from CONVOY and a timeline for offering the arm outside the trial.

The Bottom Line

CONVOY is the Neuralink trial that uses the implant to move a physical object instead of a cursor. ClinicalTrials.gov lists it as enrolling by invitation, so only people Neuralink selects can join.